Partovet 250 ml.inj.

7,06 € /Unit

6,42€ no IVA

Hormonal drug, whose active ingredient is oxytocin. Indicated in cows, sheep, goats, sows, mares, bitches and cats for: labour induction, expulsion of the placenta, initiation of lactation after labour and uterine involution after caesarean section. For the treatment of uterine atony, agalaxy in sows, pyometra and chronic endometritis and as a combination therapy with antibiotics for the treatment of mastitis.

Active principles:
Oxytocin
Target species:
GOAT (BREEDERS) *, Sows, Breeding cats, Ovine, Breeding bitches, Cows, Mares, Sheep
Laboratory:
Divasa-Farmavic, S.A.
Prescription:
You need a prescription
Product temporarily unavailable

Data sheet

Pharmaceutical form
Injectable solution
Administration routes
  • Intramuscular via
  • Intravenously
  • Subcutaneous via
Dose *
3 a 5 ml obstetricia, 0,5 a 2 eyeccion lactea
Contraindications
  • Gestant animals
  • Non-dilated uterine neck
  • Pelvic-fetal disproportion
  • Distocia
  • Cardiovascular diseases
  • Females predisposed to uterine rupture
  • Do not use in case of hypersensitivity to the active substance / s or any excipient.
Pharmaceutical form
Injectable solution
Administration routes
  • Intramuscular via
  • Intravenously
  • Subcutaneous via
Dose *
3 a 5 ml obstetricia, 0,5 a 2 eyeccion lactea
Withdrawal period
Meat: 0 Days
Contraindications
  • Gestant animals
  • Non-dilated uterine neck
  • Pelvic-fetal disproportion
  • Distocia
  • Cardiovascular diseases
  • Females predisposed to uterine rupture
  • Do not use in case of hypersensitivity to the active substance / s or any excipient.
Pharmaceutical form
Injectable solution
Administration routes
  • Intramuscular via
  • Intravenously
  • Subcutaneous via
Contraindications
  • Gestant animals
  • Non-dilated uterine neck
  • Pelvic-fetal disproportion
  • Distocia
  • Cardiovascular diseases
  • Females predisposed to uterine rupture
  • Do not use in case of hypersensitivity to the active substance / s or any excipient.
Pharmaceutical form
Injectable solution
Administration routes
  • Intramuscular via
  • Intravenously
  • Subcutaneous via
Dose *
3 a 5 ml obstetricia, 0,5 a 2 eyeccion lactea
Contraindications
  • Gestant animals
  • Non-dilated uterine neck
  • Pelvic-fetal disproportion
  • Distocia
  • Cardiovascular diseases
  • Females predisposed to uterine rupture
  • Do not use in case of hypersensitivity to the active substance / s or any excipient.
Pharmaceutical form
Injectable solution
Administration routes
  • Intramuscular via
  • Intravenously
  • Subcutaneous via
Contraindications
  • Gestant animals
  • Non-dilated uterine neck
  • Pelvic-fetal disproportion
  • Distocia
  • Cardiovascular diseases
  • Females predisposed to uterine rupture
  • Do not use in case of hypersensitivity to the active substance / s or any excipient.
Pharmaceutical form
Injectable solution
Administration routes
  • Intramuscular via
  • Intravenously
  • Subcutaneous via
Dose *
7,5 a 10 ml obstetricia, 1 a 2 eyeccion lactea
Withdrawal period
  • Meat: 0 Days
  • Milk: 0 Days
Contraindications
  • Gestant animals
  • Non-dilated uterine neck
  • Pelvic-fetal disproportion
  • Distocia
  • Cardiovascular diseases
  • Females predisposed to uterine rupture
  • Do not use in case of hypersensitivity to the active substance / s or any excipient.
Pharmaceutical form
Injectable solution
Administration routes
  • Intramuscular via
  • Intravenously
  • Subcutaneous via
Dose *
7,5 a 15 ml obstetricia, 1 a 2 eyeccion lactea
Contraindications
  • Gestant animals
  • Non-dilated uterine neck
  • Pelvic-fetal disproportion
  • Distocia
  • Cardiovascular diseases
  • Females predisposed to uterine rupture
  • Do not use in case of hypersensitivity to the active substance / s or any excipient.
Pharmaceutical form
Injectable solution
Administration routes
  • Intramuscular via
  • Intravenously
  • Subcutaneous via
Dose *
3 a 5 ml obstetricia, 0,5 a 2 eyeccion lactea
Withdrawal period
  • Meat: 0 Days
  • Milk: 0 Days
Contraindications
  • Gestant animals
  • Non-dilated uterine neck
  • Pelvic-fetal disproportion
  • Distocia
  • Cardiovascular diseases
  • Females predisposed to uterine rupture
  • Do not use in case of hypersensitivity to the active substance / s or any excipient.

* Doses taken from official sources

related products

Any doubts?

Contactanos por teléfono, WhatsApp o email